Anticancer Activity of ST101, A Novel Antagonist of CCAAT/Enhancer Binding Protein β
Emad Darvishi(Io Therapeutics (United States)), Jimmy A. Rotolo(Io Therapeutics (United States))
Cited by 19
Related Papers
Caspase-dependent and -independent Activation of Acid Sphingomyelinase Signaling
|Journal of Biological Chemistry|2005|162